Pharmaceutical business Remedi Pharmacy Solutions has secured a £250,000 loan to support the development of its latest software platform and enable it to create seven new jobs.

Kuano.ai, a software platform for rapid, cost effective quantum modelling of enzymes, has raised £1 million in seed funding from ACF Investors, o2h Ventures and a syndicate of Cambridge-based angel investors. The funding will accelerate the company’s growth as it moves further towards commercialisation.

Foresight Group, the award-winning listed private equity and infrastructure investment manager, has announced a £1.5m follow-on investment into portfolio company Biotherapy Services Ltd, a leading pharmaceutical biotech company.  The funds will be used to support the clinical development of RAPID^TM Biodynamic Haematogel, currently in phase 2b/3 clinical trials in the treatment of DFUs.

QV Bioelectronics – a medical device start-up pioneering a first of its kind electric field therapy implant for the treatment of the most common and aggressive type of brain tumours, has closed a £735,000 seed funding round to advance the development of its innovative GRACE implant.

MediSieve Ltd, a biotech company which has developed an innovative blood filtration device, has completed a £1.8m investment, led by 24Haymarket.

Thymia has raised a £780k/$1.1m pre-seed round to scale its platform to assess for and monitor depression. The Thymia technology removes the subjectivity from mental health assessments: instead of answering questionnaires, patients play specially designed video games which use cutting-edge Neuropsychology, Linguistics and Machine Learning to detect signs of depression, as well as monitor whether symptoms are improving or worsening over time. 

Turquoise, the UK merchant bank specialising in energy, environment and efficiency, has invested in Ablatus Therapeutics for the Low Carbon Innovation Fund 2 (LCIF2). The investment of £85,000 is part of an overall round which could reach £1.5 million.

Ablatus Therapeutics is developing Bimodal Electric Tissue Ablation (BETA), an innovative improvement over existing tissue ablation techniques, in order to offer greater clinical options and to improve patient outcomes. 

Epipole, the video retinal imaging specialist, has started work on a €1.1 million collaborative project to develop a technology solution for the diagnosis of intracranial pressure (ICP). The project is funded by the Eureka Eurostars programme, and is a collaboration between Epipole, Denmark’s Statumanu ICP and the University of Southern Denmark.

Foresight Group has invested 3 million of growth capital into NorthWest EHealth Limited, providers of software and services to the clinical trials market.

Navenio, the UK company that has pioneered indoor location-based artificial intelligence to revolutionise workflows and can double the throughput of hospital teams, has been successful in securing funding in the latest round of the Artificial Intelligence in Health and Care Award.

Foresight Group has made a £300,000 growth capital investment from the Midlands Engine Investment Fund (MEIF) into ReadyGo Diagnostics Limited, a start-up diagnostics business. 

UK-based healthtech firm Kiteline, formerly known as Liminal Health, has secured £370,000 in funding to meet the demand for support for those living with chronic conditions, including cancer, diabetes, heart disease, and, most recently, long COVID.